Angiodynamic Inc. (ANGO) NASDAQ
$5.88 0.18 (3.16%)
Market Cap: $227.17M
As of 03/28/24 03:59 PM EDT. Market closed.
Angiodynamic Inc. (ANGO)
NASDAQ
$5.88
0.18 (3.16%)
Market Cap: $227.17M
As of 03/28/24 03:59 PM EDT. Market closed.
founded in 1988 in queensbury, n.y., u.s., angiodynamics is today a nasdaq-listed public company. we are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. our diverse product line includes market-leading radiofrequency ablation and nanoknife® systems, ... read more
founded in 1988 in queensbury, n.y., u.s., angiodynamics is today a nasdaq-listed public company. we are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. our diverse product line includes market-leading radiofrequency ablation and nanoknife® systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. angiodynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. angiodynamics believes it is well poised to continue that trend. looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patie read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Trowbridge Stephen A | EVP and CFO | Feb 29, 2024 | Option Exercise | $4.67 | 1,927 | 8,999 | 128,901 | Mar 04, 2024, 08:49 PM |
Trowbridge Stephen A | EVP and CFO | Jul 19, 2023 | Option Exercise | $8.92 | 6,975 | 62,217 | 126,974 | Sep 21, 2023, 09:28 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 19, 2023 | Option Exercise | $8.92 | 3,477 | 31,015 | 34,462 | Sep 21, 2023, 09:23 PM |
Centea Scott | SVP/GM, VIT | Jul 19, 2023 | Option Exercise | $8.92 | 2,716 | 24,227 | 62,951 | Sep 21, 2023, 09:17 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 19, 2023 | Option Exercise | $8.92 | 3,103 | 27,679 | 53,016 | Sep 21, 2023, 09:12 PM |
Clemmer James C | President and CEO | Jul 19, 2023 | Option Exercise | $8.92 | 34,296 | 305,920 | 564,446 | Sep 21, 2023, 09:07 PM |
Clemmer James C | President and CEO | Jul 19, 2023 | Option Exercise | $8.92 | 11,379 | 101,501 | 549,259 | Jul 26, 2023, 09:32 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 19, 2023 | Option Exercise | $8.92 | 1,575 | 14,049 | 31,085 | Jul 26, 2023, 09:32 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 19, 2023 | Option Exercise | $8.92 | 1,404 | 12,524 | 50,005 | Jul 26, 2023, 09:32 PM |
Centea Scott | SVP/GM, VIT | Jul 19, 2023 | Option Exercise | $8.92 | 1,230 | 10,972 | 60,313 | Jul 26, 2023, 09:32 PM |
Trowbridge Stephen A | EVP and CFO | Jul 19, 2023 | Option Exercise | $8.92 | 3,159 | 28,178 | 120,205 | Jul 26, 2023, 09:32 PM |
Trowbridge Stephen A | EVP and CFO | Jul 21, 2023 | Option Exercise | $8.65 | 667 | 5,770 | 114,595 | Jul 25, 2023, 07:07 PM |
Trowbridge Stephen A | EVP and CFO | Jul 20, 2023 | Option Exercise | $8.74 | 717 | 6,267 | 115,262 | Jul 25, 2023, 07:07 PM |
Clemmer James C | President and CEO | Jul 21, 2023 | Option Exercise | $8.65 | 3,372 | 29,168 | 529,066 | Jul 25, 2023, 07:07 PM |
Clemmer James C | President and CEO | Jul 20, 2023 | Option Exercise | $8.74 | 2,982 | 26,063 | 532,438 | Jul 25, 2023, 07:07 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 20, 2023 | Option Exercise | $8.74 | 332 | 2,902 | 28,654 | Jul 25, 2023, 07:07 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 21, 2023 | Option Exercise | $8.65 | 365 | 3,157 | 28,289 | Jul 25, 2023, 07:07 PM |
Centea Scott | SVP/GM, VIT | Jul 21, 2023 | Option Exercise | $8.65 | 255 | 2,206 | 58,128 | Jul 25, 2023, 07:06 PM |
Centea Scott | SVP/GM, VIT | Jul 20, 2023 | Option Exercise | $8.74 | 333 | 2,910 | 58,383 | Jul 25, 2023, 07:06 PM |
Piccinini Laura | SVP International | Jul 21, 2023 | Option Exercise | $8.65 | 413 | 3,572 | 19,093 | Jul 25, 2023, 07:06 PM |
Piccinini Laura | SVP International | Jul 20, 2023 | Option Exercise | $8.74 | 616 | 5,384 | 19,506 | Jul 25, 2023, 07:06 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 21, 2023 | Option Exercise | $8.65 | 395 | 3,417 | 47,509 | Jul 25, 2023, 07:06 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 20, 2023 | Option Exercise | $8.74 | 359 | 3,138 | 47,904 | Jul 25, 2023, 07:06 PM |
Trowbridge Stephen A | EVP and CFO | Jul 14, 2023 | Option Exercise | $9.63 | 1,362 | 13,116 | 87,664 | Jul 18, 2023, 08:13 PM |
Trowbridge Stephen A | EVP and CFO | Jul 17, 2023 | Option Exercise | $9.56 | 376 | 3,595 | 87,288 | Jul 18, 2023, 08:13 PM |
Clemmer James C | President and CEO | Jul 17, 2023 | Option Exercise | $9.56 | 2,262 | 21,625 | 443,239 | Jul 18, 2023, 08:13 PM |
Clemmer James C | President and CEO | Jul 14, 2023 | Option Exercise | $9.63 | 4,906 | 47,245 | 445,501 | Jul 18, 2023, 08:13 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 17, 2023 | Option Exercise | $9.56 | 279 | 2,667 | 36,879 | Jul 18, 2023, 08:13 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 14, 2023 | Option Exercise | $9.63 | 596 | 5,739 | 37,158 | Jul 18, 2023, 08:13 PM |
Centea Scott | SVP/GM, VIT | Jul 14, 2023 | Option Exercise | $9.63 | 517 | 4,979 | 48,479 | Jul 18, 2023, 08:13 PM |
Centea Scott | SVP/GM, VIT | Jul 17, 2023 | Option Exercise | $9.56 | 351 | 3,356 | 48,128 | Jul 18, 2023, 08:13 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 17, 2023 | Option Exercise | $9.56 | 313 | 2,992 | 18,197 | Jul 18, 2023, 08:13 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 14, 2023 | Option Exercise | $9.63 | 679 | 6,539 | 18,510 | Jul 18, 2023, 08:13 PM |
Piccinini Laura | SVP International | Jun 01, 2023 | Option Exercise | $9.64 | 1,400 | 13,496 | 5,954 | Jun 02, 2023, 03:36 PM |
Trowbridge Stephen A | EVP and CFO | Feb 03, 2023 | Option Exercise | $13.43 | 555 | 7,454 | 89,026 | Feb 07, 2023, 04:02 PM |
ROSENZWEIG RICHARD C | SVP and General Counsel | Feb 01, 2023 | Option Exercise | $13.36 | 1,137 | 15,190 | 15,730 | Feb 07, 2023, 04:00 PM |
Helsel Dave | SVP Global Operations and R&D | Jan 31, 2023 | Sale | $12.95 | 4,633 | 59,997 | 19,189 | Feb 01, 2023, 04:07 PM |
Trowbridge Stephen A | EVP and CFO | Oct 12, 2022 | Buy | $13.82 | 1,083 | 14,967 | 89,581 | Oct 12, 2022, 05:23 PM |
Clemmer James C | President and CEO | Oct 10, 2022 | Buy | $15.00 | 10,000 | 150,000 | 450,407 | Oct 11, 2022, 04:06 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 29, 2022 | Sale | $22.44 | 5,000 | 112,200 | 23,822 | Aug 01, 2022, 04:19 PM |
JOHNSON WESLEY | Director | Jul 15, 2022 | Option Exercise | $21.32 | 4,505 | 96,047 | 81,221 | Jul 18, 2022, 04:16 PM |
JOHNSON WESLEY | Director | Jul 15, 2022 | Option Exercise | $15.95 | 6,022 | 96,051 | 85,726 | Jul 18, 2022, 04:16 PM |
Trowbridge Stephen A | EVP and CFO | Jul 15, 2022 | Option Exercise | $21.32 | 12,398 | 264,325 | 80,537 | Jul 18, 2022, 04:13 PM |
Trowbridge Stephen A | EVP and CFO | Jul 15, 2022 | Option Exercise | $15.95 | 14,758 | 235,390 | 92,935 | Jul 18, 2022, 04:13 PM |
Meteny Dennis S | Director | Jul 12, 2022 | Option Exercise | $20.02 | 4,798 | 96,056 | 115,918 | Jul 14, 2022, 04:15 PM |
Meteny Dennis S | Director | Jul 12, 2022 | Option Exercise | $15.95 | 6,022 | 96,051 | 120,716 | Jul 14, 2022, 04:15 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 07, 2022 | Option Exercise | $20.54 | 1,223 | 25,120 | 25,131 | Jul 11, 2022, 06:20 AM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 07, 2022 | Option Exercise | $20.54 | 1,078 | 22,142 | 33,767 | Jul 11, 2022, 06:17 AM |
Nighan Warren JR | SVP Quality and Regulatory | Jul 07, 2022 | Option Exercise | $20.54 | 919 | 18,876 | 36,193 | Jul 11, 2022, 06:15 AM |
Trowbridge Stephen A | EVP and CFO | Jul 07, 2022 | Option Exercise | $20.54 | 1,509 | 30,995 | 78,177 | Jul 11, 2022, 06:12 AM |
Clemmer James C | President and CEO | Jul 07, 2022 | Option Exercise | $20.54 | 8,574 | 176,110 | 407,313 | Jul 11, 2022, 06:08 AM |
Helsel Dave | SVP Global Operations and R&D | Apr 28, 2022 | Sale | $22.44 | 3,513 | 78,832 | 22,874 | May 02, 2022, 06:04 AM |
DONNELLY HOWARD W | Director | Apr 20, 2022 | Option Exercise | $15.95 | 6,022 | 96,051 | 104,734 | Apr 21, 2022, 05:13 PM |
JOHNSON WESLEY | Director | Apr 12, 2022 | Sale | $23.26 | 1,299 | 30,215 | 79,704 | Apr 13, 2022, 04:07 PM |
JOHNSON WESLEY | Director | Apr 11, 2022 | Sale | $23.00 | 6,201 | 142,623 | 80,003 | Apr 13, 2022, 04:07 PM |
Trowbridge Stephen A | EVP and CFO | Feb 03, 2022 | Option Exercise | $20.48 | 583 | 11,940 | 75,498 | Feb 04, 2022, 04:38 PM |
ROSENZWEIG RICHARD C | SVP and General Counsel | Feb 01, 2022 | Option Exercise | $21.31 | 1,194 | 25,444 | 12,904 | Feb 03, 2022, 04:14 PM |
Trowbridge Stephen A | EVP and CFO | Jan 12, 2022 | Buy | $22.64 | 1,000 | 22,640 | 76,081 | Jan 12, 2022, 04:44 PM |
Clemmer James C | President and CEO | Jan 11, 2022 | Buy | $22.84 | 10,000 | 228,400 | 390,764 | Jan 12, 2022, 04:35 PM |
Centea Scott | Sr. VP/GM, Global VIT | Oct 31, 2021 | Option Exercise | $29.37 | 953 | 27,990 | 45,291 | Nov 05, 2021, 04:28 PM |
Helsel Dave | SVP Global Operations and R&D | Oct 20, 2021 | Sale | $27.97 | 3,494 | 97,727 | 26,387 | Oct 21, 2021, 04:50 PM |
Centea Scott | Sr. VP/GM, Global VIT | Oct 15, 2021 | Option Exercise | $16.77 | 12,000 | 201,240 | 58,244 | Oct 18, 2021, 04:45 PM |
Centea Scott | Sr. VP/GM, Global VIT | Oct 15, 2021 | Sale | $27.92 | 12,000 | 335,040 | 46,244 | Oct 18, 2021, 04:45 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Oct 05, 2021 | Option Exercise | $16.59 | 10,748 | 178,309 | 42,489 | Oct 06, 2021, 06:39 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Oct 05, 2021 | Sale | $27.15 | 10,748 | 291,808 | 31,741 | Oct 06, 2021, 06:39 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Aug 12, 2021 | Option Exercise | $27.29 | 3,130 | 85,418 | 31,741 | Aug 18, 2021, 07:11 AM |
Clemmer James C | President and CEO | Aug 12, 2021 | Option Exercise | $27.29 | 21,532 | 587,608 | 378,163 | Aug 18, 2021, 07:08 AM |
Trowbridge Stephen A | EVP and CFO | Aug 12, 2021 | Option Exercise | $27.29 | 4,173 | 113,881 | 75,081 | Aug 18, 2021, 07:02 AM |
Helsel Dave | SVP Global Operations and R&D | Aug 12, 2021 | Option Exercise | $27.29 | 3,347 | 91,340 | 29,881 | Aug 18, 2021, 06:59 AM |
Helsel Dave | SVP Global Operations and R&D | Aug 12, 2021 | Option Exercise | $27.29 | 788 | 21,505 | 23,719 | Aug 17, 2021, 06:50 AM |
Clemmer James C | President and CEO | Aug 12, 2021 | Option Exercise | $27.29 | 9,021 | 246,183 | 369,533 | Aug 17, 2021, 06:49 AM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Aug 12, 2021 | Option Exercise | $27.29 | 702 | 19,158 | 28,354 | Aug 17, 2021, 06:48 AM |
Trowbridge Stephen A | EVP and CFO | Aug 12, 2021 | Option Exercise | $27.29 | 1,231 | 33,594 | 70,308 | Aug 17, 2021, 06:23 AM |
Meteny Dennis S | Director | Jul 28, 2021 | Option Exercise | $26.43 | 3,171 | 83,810 | 114,694 | Jul 30, 2021, 06:31 PM |
Meteny Dennis S | Director | Jul 28, 2021 | Option Exercise | $14.64 | 5,726 | 83,829 | 117,865 | Jul 30, 2021, 06:31 PM |
JOHNSON WESLEY | Director | Jul 28, 2021 | Option Exercise | $26.43 | 3,171 | 83,810 | 86,204 | Jul 30, 2021, 06:27 PM |
JOHNSON WESLEY | Director | Jul 28, 2021 | Option Exercise | $14.64 | 5,726 | 83,829 | 89,375 | Jul 30, 2021, 06:27 PM |
Centea Scott | Sr. VP/GM, Global VIT | Jul 26, 2021 | Option Exercise | $26.10 | 419 | 10,936 | 46,244 | Jul 27, 2021, 07:05 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 26, 2021 | Option Exercise | $26.10 | 318 | 8,300 | 26,661 | Jul 27, 2021, 07:01 PM |
Trowbridge Stephen A | EVP and CFO | Jul 26, 2021 | Option Exercise | $26.10 | 353 | 9,213 | 68,308 | Jul 27, 2021, 07:01 PM |
Clemmer James C | President and CEO | Jul 26, 2021 | Option Exercise | $26.10 | 2,105 | 54,941 | 359,167 | Jul 27, 2021, 06:43 PM |
Trowbridge Stephen A | EVP and CFO | Jul 17, 2021 | Option Exercise | $24.76 | 354 | 8,765 | 61,653 | Jul 23, 2021, 06:53 PM |
Trowbridge Stephen A | EVP and CFO | Jul 14, 2021 | Option Exercise | $26.43 | 1,284 | 33,936 | 62,007 | Jul 23, 2021, 06:53 PM |
Trowbridge Stephen A | EVP and CFO | Jul 18, 2021 | Option Exercise | $24.76 | 400 | 9,904 | 61,253 | Jul 23, 2021, 06:53 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 18, 2021 | Option Exercise | $24.76 | 417 | 10,325 | 17,764 | Jul 23, 2021, 06:50 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 17, 2021 | Option Exercise | $24.76 | 294 | 7,279 | 18,181 | Jul 23, 2021, 06:50 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 14, 2021 | Option Exercise | $26.43 | 640 | 16,915 | 18,475 | Jul 23, 2021, 06:50 PM |
Centea Scott | SVP/GM, VIT | Jul 14, 2021 | Option Exercise | $26.43 | 500 | 13,215 | 44,504 | Jul 23, 2021, 06:47 PM |
Centea Scott | SVP/GM, VIT | Jul 18, 2021 | Option Exercise | $24.76 | 344 | 8,517 | 43,821 | Jul 23, 2021, 06:47 PM |
Centea Scott | SVP/GM, VIT | Jul 17, 2021 | Option Exercise | $24.76 | 339 | 8,394 | 44,165 | Jul 23, 2021, 06:47 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 18, 2021 | Option Exercise | $24.76 | 300 | 7,428 | 22,591 | Jul 23, 2021, 06:45 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 17, 2021 | Option Exercise | $24.76 | 262 | 6,487 | 22,891 | Jul 23, 2021, 06:45 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 14, 2021 | Option Exercise | $26.43 | 571 | 15,092 | 23,153 | Jul 23, 2021, 06:45 PM |
Clemmer James C | President and CEO | Jul 14, 2021 | Option Exercise | $26.43 | 4,622 | 122,159 | 338,697 | Jul 23, 2021, 06:42 PM |
Clemmer James C | President and CEO | Jul 18, 2021 | Option Exercise | $24.76 | 1,483 | 36,719 | 335,083 | Jul 23, 2021, 06:42 PM |
Clemmer James C | President and CEO | Jul 17, 2021 | Option Exercise | $24.76 | 2,131 | 52,764 | 336,566 | Jul 23, 2021, 06:42 PM |
Helsel Dave | SVP Global Operations and R&D | Apr 14, 2021 | Sale | $23.93 | 3,500 | 83,755 | 19,115 | Apr 15, 2021, 04:20 PM |
DONNELLY HOWARD W | Director | Apr 01, 2021 | Option Exercise | $23.15 | 3,621 | 83,826 | 92,974 | Apr 05, 2021, 05:53 PM |
DONNELLY HOWARD W | Director | Apr 01, 2021 | Option Exercise | $14.64 | 5,726 | 83,829 | 96,595 | Apr 05, 2021, 05:53 PM |
Trowbridge Stephen A | EVP and CFO | Feb 03, 2021 | Option Exercise | $19.24 | 527 | 10,139 | 59,746 | Feb 04, 2021, 04:27 PM |
JOHNSON WESLEY | Director | Jan 20, 2021 | Sale | $18.53 | 6,500 | 120,445 | 77,911 | Jan 21, 2021, 10:15 AM |
Helsel Dave | SVP Global Operations and R&D | Dec 18, 2020 | Option Exercise | $14.29 | 733 | 10,475 | 22,615 | Dec 21, 2020, 06:05 PM |
Centea Scott | SVP/GM, VIT | Oct 31, 2020 | Option Exercise | $10.62 | 849 | 9,016 | 45,004 | Nov 03, 2020, 04:22 PM |
Trowbridge Stephen A | EVP and CFO | Aug 11, 2020 | Buy | $9.38 | 1,013 | 9,502 | 60,273 | Aug 12, 2020, 04:14 PM |
Clemmer James C | President and CEO | Jul 31, 2020 | Buy | $8.26 | 40,000 | 330,400 | 343,319 | Aug 03, 2020, 05:27 PM |
Trowbridge Stephen A | EVP and CFO | Jul 27, 2020 | Option Exercise | $8.80 | 292 | 2,570 | 59,260 | Jul 28, 2020, 04:43 PM |
Trowbridge Stephen A | EVP and CFO | Jul 26, 2020 | Option Exercise | $8.80 | 314 | 2,763 | 59,552 | Jul 28, 2020, 04:43 PM |
Clemmer James C | President and CEO | Jul 26, 2020 | Option Exercise | $8.80 | 1,876 | 16,509 | 305,118 | Jul 28, 2020, 04:38 PM |
Clemmer James C | President and CEO | Jul 27, 2020 | Option Exercise | $8.80 | 1,799 | 15,831 | 303,319 | Jul 28, 2020, 04:38 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 27, 2020 | Option Exercise | $8.80 | 259 | 2,279 | 23,724 | Jul 28, 2020, 04:27 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 26, 2020 | Option Exercise | $8.80 | 283 | 2,490 | 23,983 | Jul 28, 2020, 04:27 PM |
Trowbridge Stephen A | EVP and CFO | Jul 18, 2020 | Option Exercise | $9.21 | 400 | 3,684 | 60,018 | Jul 21, 2020, 07:36 PM |
Trowbridge Stephen A | EVP and CFO | Jul 17, 2020 | Option Exercise | $9.46 | 354 | 3,349 | 60,266 | Jul 21, 2020, 07:36 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 17, 2020 | Option Exercise | $9.46 | 254 | 2,403 | 23,708 | Jul 21, 2020, 07:34 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 18, 2020 | Option Exercise | $9.21 | 362 | 3,334 | 23,501 | Jul 21, 2020, 07:34 PM |
Clemmer James C | President and CEO | Jul 18, 2020 | Option Exercise | $9.21 | 1,483 | 13,658 | 306,994 | Jul 21, 2020, 07:33 PM |
Clemmer James C | President and CEO | Jul 17, 2020 | Option Exercise | $9.46 | 2,131 | 20,159 | 308,477 | Jul 21, 2020, 07:33 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 18, 2020 | Option Exercise | $9.21 | 300 | 2,763 | 24,342 | Jul 21, 2020, 07:31 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 17, 2020 | Option Exercise | $9.46 | 262 | 2,479 | 24,566 | Jul 21, 2020, 07:31 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | May 23, 2020 | Option Exercise | $11.21 | 826 | 9,259 | 18,102 | May 27, 2020, 08:56 PM |
Clemmer James C | President and CEO | Apr 04, 2020 | Option Exercise | $10.23 | 4,245 | 43,426 | 256,173 | Apr 07, 2020, 04:11 PM |
Boucher Brent J. | SVP and GM of Oncology | Feb 12, 2020 | Option Exercise | $12.99 | 490 | 6,365 | 15,416 | Feb 18, 2020, 07:03 PM |
Boucher Brent J. | SVP and GM of Oncology | Jan 17, 2020 | Option Exercise | $15.48 | 490 | 7,585 | 15,906 | Jan 21, 2020, 04:17 PM |
Helsel Dave | SVP Global Operations and R&D | Dec 18, 2019 | Option Exercise | $15.57 | 736 | 11,460 | 16,422 | Dec 20, 2019, 05:14 PM |
Clemmer James C | President and CEO | Oct 25, 2019 | Buy | $14.19 | 15,000 | 212,850 | 260,418 | Oct 28, 2019, 08:13 AM |
Greiner Michael | EVP and CFO | Aug 18, 2019 | Option Exercise | $19.10 | 826 | 15,777 | 33,438 | Aug 20, 2019, 06:52 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 12, 2019 | Option Exercise | $21.68 | 1,185 | 25,691 | 40,123 | Aug 20, 2019, 06:14 AM |
Greiner Michael | EVP and CFO | Jul 12, 2019 | Option Exercise | $21.68 | 3,440 | 74,579 | 34,264 | Aug 20, 2019, 06:08 AM |
Simpson Robert Arthur | SVP/GM, Global Vascular | Jul 12, 2019 | Option Exercise | $21.68 | 5,158 | 111,825 | 25,883 | Aug 19, 2019, 10:00 PM |
Clemmer James C | President and CEO | Jul 12, 2019 | Option Exercise | $21.68 | 96,140 | 2,084,315 | 245,418 | Aug 19, 2019, 09:59 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 12, 2019 | Option Exercise | $21.68 | 1,050 | 22,764 | 21,052 | Aug 19, 2019, 09:58 PM |
JOHNSON WESLEY | Director | Aug 06, 2019 | Option Exercise | $19.83 | 3,581 | 71,011 | 69,088 | Aug 09, 2019, 05:41 PM |
JOHNSON WESLEY | Director | Aug 06, 2019 | Option Exercise | $10.68 | 6,650 | 71,022 | 72,669 | Aug 09, 2019, 05:41 PM |
Clemmer James C | President and CEO | Jul 26, 2019 | Option Exercise | $20.89 | 1,826 | 38,145 | 143,310 | Aug 02, 2019, 04:33 PM |
Clemmer James C | President and CEO | Jul 27, 2019 | Option Exercise | $20.91 | 1,752 | 36,634 | 141,558 | Aug 02, 2019, 04:33 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 27, 2019 | Option Exercise | $20.91 | 252 | 5,269 | 18,928 | Aug 02, 2019, 04:31 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 26, 2019 | Option Exercise | $20.89 | 276 | 5,766 | 19,180 | Aug 02, 2019, 04:31 PM |
Simpson Robert Arthur | SVP/GM, Global Vascular | Jul 26, 2019 | Option Exercise | $20.89 | 309 | 6,455 | 15,441 | Aug 02, 2019, 04:29 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 27, 2019 | Option Exercise | $20.91 | 285 | 5,959 | 37,723 | Aug 02, 2019, 04:26 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 26, 2019 | Option Exercise | $20.89 | 306 | 6,392 | 38,008 | Aug 02, 2019, 04:26 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 22, 2019 | Option Exercise | $21.38 | 355 | 7,590 | 38,314 | Aug 02, 2019, 04:26 PM |
Greiner Michael | EVP and CFO | Jul 26, 2019 | Option Exercise | $20.89 | 511 | 10,675 | 27,304 | Aug 02, 2019, 04:22 PM |
Greiner Michael | EVP and CFO | Jul 18, 2019 | Option Exercise | $21.53 | 576 | 12,401 | 27,987 | Jul 25, 2019, 04:59 PM |
Clemmer James C | President and CEO | Jul 18, 2019 | Option Exercise | $21.53 | 1,444 | 31,089 | 145,136 | Jul 25, 2019, 04:56 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 18, 2019 | Option Exercise | $21.53 | 292 | 6,287 | 19,530 | Jul 25, 2019, 04:54 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 22, 2019 | Option Exercise | $21.38 | 355 | 7,590 | 38,669 | Jul 25, 2019, 04:51 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 18, 2019 | Option Exercise | $21.53 | 389 | 8,375 | 39,172 | Jul 25, 2019, 04:51 PM |
Boucher Brent J. | SVP and GM of Oncology | Jul 18, 2019 | Option Exercise | $21.53 | 373 | 8,031 | 16,544 | Jul 25, 2019, 04:48 PM |
Helsel Dave | SVP Global Operations and R&D | Jul 18, 2019 | Option Exercise | $21.53 | 405 | 8,720 | 17,330 | Jul 25, 2019, 04:46 PM |
Simpson Robert Arthur | SVP/GM, Global Vascular | Jul 18, 2019 | Option Exercise | $21.53 | 392 | 8,440 | 15,898 | Jul 25, 2019, 04:42 PM |
GOLD JEFFREY | Director | Jul 12, 2019 | Option Exercise | $21.68 | 3,276 | 71,024 | 76,583 | Jul 18, 2019, 04:15 PM |
GOLD JEFFREY | Director | Jul 12, 2019 | Option Exercise | $10.68 | 6,650 | 71,022 | 79,859 | Jul 18, 2019, 04:15 PM |
Gould Kevin J | Director | Jul 16, 2019 | Option Exercise | $11.32 | 13,650 | 154,462 | 68,774 | Jul 18, 2019, 04:12 PM |
Gould Kevin J | Director | Jul 16, 2019 | Sale | $21.45 | 13,650 | 292,793 | 55,124 | Jul 18, 2019, 04:12 PM |
Meteny Dennis S | Director | Jun 28, 2019 | Option Exercise | $19.69 | 3,607 | 71,022 | 84,021 | Jul 16, 2019, 04:26 PM |
Meteny Dennis S | Director | Jun 28, 2019 | Option Exercise | $10.68 | 6,650 | 71,022 | 87,628 | Jul 16, 2019, 04:26 PM |
Meteny Dennis S | Director | May 31, 2019 | Option Exercise | $18.79 | 3,780 | 71,026 | 83,848 | Jul 03, 2019, 05:58 PM |
Meteny Dennis S | Director | May 31, 2019 | Option Exercise | $10.68 | 6,650 | 71,022 | 87,628 | Jul 03, 2019, 05:58 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | May 23, 2019 | Option Exercise | $19.15 | 858 | 16,431 | 16,650 | May 24, 2019, 12:53 PM |
Trowbridge Stephen A | SVP and General Counsel | Apr 24, 2019 | Option Exercise | $20.64 | 1,319 | 27,224 | 35,235 | Apr 25, 2019, 08:21 PM |
Clemmer James C | President and CEO | Apr 04, 2019 | Option Exercise | $22.95 | 4,232 | 97,124 | 121,476 | Apr 08, 2019, 04:09 PM |
Boucher Brent J. | SVP and GM of Oncology | Feb 12, 2019 | Option Exercise | $22.90 | 490 | 11,221 | 13,543 | Feb 14, 2019, 06:14 PM |
Simpson Robert Arthur | SVP/GM, Global Vascular | Jan 31, 2019 | Option Exercise | $21.10 | 981 | 20,699 | 16,142 | Feb 01, 2019, 04:24 PM |
Greiner Michael | EVP and CFO | Nov 07, 2018 | Sale | $21.53 | 1,939 | 41,747 | 20,731 | Nov 08, 2018, 04:06 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 12, 2018 | Option Exercise | $20.50 | 1,175 | 24,088 | 38,935 | Aug 22, 2018, 07:05 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 27, 2018 | Option Exercise | $21.42 | 285 | 6,105 | 36,554 | Jul 30, 2018, 06:57 PM |
Clemmer James C | President and CEO | Jul 27, 2018 | Option Exercise | $21.42 | 1,752 | 37,528 | 125,708 | Jul 30, 2018, 06:56 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 27, 2018 | Option Exercise | $21.42 | 252 | 5,398 | 17,508 | Jul 30, 2018, 06:53 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 26, 2018 | Option Exercise | $21.88 | 306 | 6,695 | 36,839 | Jul 27, 2018, 08:13 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 25, 2018 | Option Exercise | $21.50 | 391 | 8,407 | 37,145 | Jul 27, 2018, 08:13 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 22, 2018 | Option Exercise | $21.67 | 355 | 7,693 | 37,536 | Jul 27, 2018, 08:13 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 26, 2018 | Option Exercise | $21.88 | 276 | 6,039 | 17,760 | Jul 27, 2018, 08:08 PM |
Greiner Michael | EVP and CFO | Jul 26, 2018 | Option Exercise | $21.88 | 511 | 11,181 | 22,670 | Jul 27, 2018, 08:01 PM |
Clemmer James C | President and CEO | Jul 26, 2018 | Option Exercise | $21.88 | 1,826 | 39,953 | 127,460 | Jul 27, 2018, 07:58 PM |
Simpson Robert Arthur | SVP/GM, Global Vascular | Jul 26, 2018 | Option Exercise | $21.88 | 308 | 6,739 | 17,123 | Jul 27, 2018, 07:55 PM |
GOLD JEFFREY | Director | Jul 06, 2018 | Option Exercise | $23.65 | 4,004 | 94,695 | 66,902 | Jul 10, 2018, 06:44 PM |
GOLD JEFFREY | Director | Jul 06, 2018 | Option Exercise | $13.53 | 7,000 | 94,710 | 70,906 | Jul 10, 2018, 06:44 PM |
Meteny Dennis S | Director | Jun 21, 2018 | Option Exercise | $22.40 | 8,456 | 189,414 | 74,671 | Jun 25, 2018, 04:30 PM |
Meteny Dennis S | Director | Jun 21, 2018 | Option Exercise | $13.53 | 14,000 | 189,420 | 83,127 | Jun 25, 2018, 04:30 PM |
DONNELLY HOWARD W | Director | Jun 21, 2018 | Option Exercise | $22.40 | 3,171 | 71,030 | 62,182 | Jun 25, 2018, 04:26 PM |
DONNELLY HOWARD W | Director | Jun 21, 2018 | Option Exercise | $10.68 | 6,650 | 71,022 | 65,353 | Jun 25, 2018, 04:26 PM |
GOLD JEFFREY | Director | Jun 21, 2018 | Option Exercise | $22.40 | 4,228 | 94,707 | 63,906 | Jun 25, 2018, 04:23 PM |
GOLD JEFFREY | Director | Jun 21, 2018 | Option Exercise | $13.53 | 7,000 | 94,710 | 68,134 | Jun 25, 2018, 04:23 PM |
JOHNSON WESLEY | Director | Jun 22, 2018 | Option Exercise | $22.77 | 8,319 | 189,424 | 52,655 | Jun 25, 2018, 04:20 PM |
JOHNSON WESLEY | Director | Jun 22, 2018 | Option Exercise | $13.53 | 14,000 | 189,420 | 60,974 | Jun 25, 2018, 04:20 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | May 23, 2018 | Option Exercise | $20.37 | 827 | 16,846 | 14,497 | May 24, 2018, 08:58 PM |
Trowbridge Stephen A | SVP and General Counsel | Apr 24, 2018 | Option Exercise | $19.76 | 1,280 | 25,293 | 33,172 | Apr 25, 2018, 04:57 PM |
Simpson Robert Arthur | SVP/GM, Global Vascular | Jan 31, 2018 | Option Exercise | $17.41 | 1,056 | 18,385 | 12,683 | Feb 02, 2018, 03:12 PM |
DONNELLY HOWARD W | Director | Nov 21, 2017 | Option Exercise | $17.42 | 10,873 | 189,408 | 58,703 | Nov 22, 2017, 01:48 PM |
DONNELLY HOWARD W | Director | Nov 21, 2017 | Option Exercise | $13.53 | 14,000 | 189,420 | 69,576 | Nov 22, 2017, 01:48 PM |
Richard Stark | SVP, GM - Oncology | Nov 15, 2017 | Option Exercise | $11.45 | 27,409 | 313,815 | 48,163 | Nov 17, 2017, 04:08 PM |
Richard Stark | SVP, GM - Oncology | Nov 15, 2017 | Sale | $16.29 | 27,409 | 446,493 | 20,754 | Nov 17, 2017, 04:08 PM |
Gould Kevin J | Director | Sep 12, 2017 | Option Exercise | $18.09 | 30,247 | 547,168 | 48,817 | Sep 14, 2017, 03:24 PM |
Gould Kevin J | Director | Sep 12, 2017 | Option Exercise | $14.03 | 39,000 | 547,170 | 65,064 | Sep 14, 2017, 03:24 PM |
Trowbridge Stephen A | SVP and General Counsel | Aug 06, 2017 | Option Exercise | $16.56 | 495 | 8,197 | 34,452 | Aug 08, 2017, 05:49 PM |
JOHNSON WESLEY | Director | Jul 25, 2017 | Option Exercise | $17.12 | 12,879 | 220,488 | 48,095 | Aug 08, 2017, 05:48 PM |
JOHNSON WESLEY | Director | Jul 25, 2017 | Option Exercise | $15.75 | 14,000 | 220,500 | 60,974 | Aug 08, 2017, 05:48 PM |
Richard Stark | SVP, GM - Oncology | Aug 06, 2017 | Option Exercise | $16.56 | 502 | 8,313 | 20,754 | Aug 08, 2017, 05:46 PM |
Meteny Dennis S | Director | Jul 25, 2017 | Option Exercise | $17.12 | 12,879 | 220,488 | 70,248 | Aug 08, 2017, 05:44 PM |
Meteny Dennis S | Director | Jul 25, 2017 | Option Exercise | $15.75 | 14,000 | 220,500 | 83,127 | Aug 08, 2017, 05:44 PM |
Clemmer James C | President and CEO | Jul 27, 2017 | Option Exercise | $16.36 | 1,958 | 32,033 | 111,817 | Jul 28, 2017, 05:38 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | Jul 27, 2017 | Option Exercise | $16.36 | 282 | 4,614 | 15,324 | Jul 28, 2017, 05:35 PM |
GOLD JEFFREY | Director | Jul 25, 2017 | Option Exercise | $17.12 | 12,879 | 220,488 | 53,158 | Jul 28, 2017, 03:47 PM |
GOLD JEFFREY | Director | Jul 25, 2017 | Option Exercise | $15.75 | 14,000 | 220,500 | 66,037 | Jul 28, 2017, 03:47 PM |
Richard Stark | SVP, GM - Oncology | Jul 25, 2017 | Option Exercise | $17.12 | 432 | 7,396 | 17,608 | Jul 28, 2017, 03:15 PM |
Richard Stark | SVP, GM - Oncology | Jul 22, 2017 | Option Exercise | $16.80 | 393 | 6,602 | 18,040 | Jul 28, 2017, 03:15 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 25, 2017 | Option Exercise | $17.12 | 437 | 7,481 | 31,242 | Jul 28, 2017, 03:05 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 22, 2017 | Option Exercise | $16.80 | 397 | 6,670 | 31,679 | Jul 28, 2017, 03:05 PM |
REED JAN STERN | Director | Jul 24, 2017 | Buy | $16.00 | 316 | 5,056 | 316 | Jul 25, 2017, 02:33 PM |
DONNELLY HOWARD W | Director | Jul 21, 2017 | Buy | $15.72 | 5,000 | 78,600 | 47,600 | Jul 21, 2017, 09:46 PM |
Clemmer James C | President and CEO | Jul 21, 2017 | Buy | $15.79 | 5,000 | 78,950 | 91,683 | Jul 21, 2017, 06:43 PM |
Clemmer James C | President and CEO | Jul 20, 2017 | Buy | $15.64 | 20,000 | 312,800 | 86,683 | Jul 21, 2017, 06:43 PM |
DONNELLY HOWARD W | Director | Jun 19, 2017 | Option Exercise | $16.28 | 13,544 | 220,496 | 42,600 | Jun 21, 2017, 09:42 PM |
DONNELLY HOWARD W | Director | Jun 19, 2017 | Option Exercise | $15.75 | 14,000 | 220,500 | 56,144 | Jun 21, 2017, 09:42 PM |
Campbell Chad Thomas | SVP/GM, Vascular Access | May 23, 2017 | Option Exercise | $15.82 | 788 | 12,466 | 12,264 | May 25, 2017, 06:07 PM |
Trowbridge Stephen A | SVP and General Counsel | Apr 24, 2017 | Option Exercise | $15.78 | 1,585 | 25,011 | 32,076 | Apr 25, 2017, 04:14 PM |
Burgstahler David F | Director | Apr 12, 2017 | Sale | $16.00 | 2,350,000 | 37,600,000 | 1,446,413 | Apr 14, 2017, 04:48 PM |
Avista Capital Partners GP, LLC | 10% Owner | Apr 12, 2017 | Sale | $16.00 | 2,350,000 | 37,600,000 | 1,446,413 | Apr 14, 2017, 04:40 PM |
Clemmer James C | President and CEO | Apr 04, 2017 | Option Exercise | $17.06 | 4,508 | 76,906 | 66,683 | Apr 10, 2017, 02:00 PM |
LaPorte Steve | Director | Jan 13, 2017 | Option Exercise | $17.92 | 14,000 | 250,880 | 34,201 | Jan 17, 2017, 02:34 PM |
LaPorte Steve | Director | Jan 13, 2017 | Option Exercise | $15.75 | 14,000 | 220,500 | 48,201 | Jan 17, 2017, 02:34 PM |
Burgstahler David F | Director | Nov 18, 2016 | Option Exercise | $15.68 | 408,706 | 6,408,510 | 765,590 | Nov 22, 2016, 04:21 PM |
Burgstahler David F | Director | Nov 18, 2016 | Sale | $15.68 | 2,091,294 | 32,791,491 | 2,903,360 | Nov 22, 2016, 04:21 PM |
Avista Capital Partners GP, LLC | 10% Owner | Nov 18, 2016 | Option Exercise | $15.68 | 408,706 | 6,408,510 | 765,590 | Nov 22, 2016, 04:20 PM |
Avista Capital Partners GP, LLC | 10% Owner | Nov 18, 2016 | Sale | $15.68 | 2,091,294 | 32,791,491 | 2,903,360 | Nov 22, 2016, 04:20 PM |
Meteny Dennis S | Director | Aug 31, 2016 | Option Exercise | $16.54 | 9,642 | 159,479 | 61,151 | Sep 06, 2016, 06:54 PM |
Meteny Dennis S | Director | Aug 31, 2016 | Option Exercise | $13.29 | 12,000 | 159,480 | 70,793 | Sep 06, 2016, 06:54 PM |
GOLD JEFFREY | Director | Aug 31, 2016 | Option Exercise | $16.54 | 9,642 | 159,479 | 52,037 | Sep 06, 2016, 06:51 PM |
GOLD JEFFREY | Director | Aug 31, 2016 | Option Exercise | $13.29 | 12,000 | 159,480 | 61,679 | Sep 06, 2016, 06:51 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 11, 2016 | Option Exercise | $14.48 | 1,698 | 24,587 | 33,661 | Aug 18, 2016, 09:15 PM |
Trowbridge Stephen A | SVP and General Counsel | Aug 08, 2016 | Option Exercise | $15.49 | 497 | 7,699 | 30,783 | Aug 09, 2016, 05:25 PM |
Burgstahler David F | Director | Aug 05, 2016 | Sale | $14.62 | 2,250,000 | 32,895,000 | 4,453,305 | Aug 05, 2016, 04:42 PM |
Avista Capital Partners GP, LLC | 10% Owner | Aug 05, 2016 | Sale | $14.62 | 2,241,000 | 32,763,420 | 4,453,305 | Aug 05, 2016, 04:39 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 25, 2016 | Option Exercise | $16.49 | 439 | 7,239 | 27,833 | Jul 27, 2016, 05:13 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 22, 2016 | Option Exercise | $16.52 | 399 | 6,591 | 28,272 | Jul 26, 2016, 06:19 PM |
DONNELLY HOWARD W | Director | Jul 15, 2016 | Option Exercise | $16.20 | 9,844 | 159,473 | 37,081 | Jul 18, 2016, 08:16 PM |
DONNELLY HOWARD W | Director | Jul 15, 2016 | Option Exercise | $13.29 | 12,000 | 159,480 | 46,925 | Jul 18, 2016, 08:16 PM |
JOHNSON WESLEY | Director | Jul 15, 2016 | Option Exercise | $16.20 | 9,844 | 159,473 | 33,935 | Jul 18, 2016, 08:14 PM |
JOHNSON WESLEY | Director | Jul 15, 2016 | Option Exercise | $13.29 | 12,000 | 159,480 | 43,779 | Jul 18, 2016, 08:14 PM |
LaPorte Steve | Director | Jul 13, 2016 | Option Exercise | $15.94 | 10,005 | 159,480 | 29,138 | Jul 15, 2016, 07:25 PM |
LaPorte Steve | Director | Jul 13, 2016 | Option Exercise | $13.29 | 12,000 | 159,480 | 39,143 | Jul 15, 2016, 07:25 PM |
Greiner Charles R | VP - Global Franchise | May 06, 2016 | Sale | $12.31 | 3,508 | 43,183 | 20,910 | May 09, 2016, 04:05 PM |
Trowbridge Stephen A | SVP and General Counsel | Apr 25, 2016 | Option Exercise | $12.23 | 1,358 | 16,608 | 28,671 | Apr 25, 2016, 06:59 PM |
Trowbridge Stephen A | SVP and General Counsel | Apr 21, 2016 | Sale | $12.33 | 10,500 | 129,465 | 32,469 | Apr 25, 2016, 06:59 PM |
Trowbridge Stephen A | SVP and General Counsel | Apr 25, 2016 | Sale | $12.18 | 2,440 | 29,719 | 30,029 | Apr 25, 2016, 06:59 PM |
SOTO JOHN | SVP and CCO | Sep 10, 2015 | Option Exercise | $14.51 | 816 | 11,840 | 22,452 | Sep 11, 2015, 08:39 PM |
DEVIVO JOSEPH | President and CEO | Sep 08, 2015 | Option Exercise | $14.52 | 2,320 | 33,686 | 198,451 | Sep 11, 2015, 08:36 PM |
SOTO JOHN | SVP and CCO | Aug 06, 2015 | Option Exercise | $15.91 | 492 | 7,828 | 23,268 | Aug 07, 2015, 04:51 PM |
Trowbridge Stephen A | SVP and General Counsel | Aug 06, 2015 | Option Exercise | $15.91 | 485 | 7,716 | 42,969 | Aug 07, 2015, 04:49 PM |
Greiner Charles R | VP - Global Franchise | Aug 06, 2015 | Option Exercise | $15.91 | 465 | 7,398 | 24,418 | Aug 07, 2015, 04:47 PM |
Richard Stark | SVP, GM - Oncology | Aug 06, 2015 | Option Exercise | $15.91 | 477 | 7,589 | 30,528 | Aug 07, 2015, 04:45 PM |
Frost Mark T | EVP and CFO | Aug 06, 2015 | Option Exercise | $15.91 | 797 | 12,680 | 38,389 | Aug 07, 2015, 04:44 PM |
DEVIVO JOSEPH | President and CEO | Aug 06, 2015 | Option Exercise | $15.91 | 1,660 | 26,411 | 200,771 | Aug 07, 2015, 04:42 PM |
Meteny Dennis S | Director | Aug 05, 2015 | Option Exercise | $15.81 | 5,795 | 91,619 | 53,730 | Aug 07, 2015, 04:39 PM |
Meteny Dennis S | Director | Aug 05, 2015 | Option Exercise | $15.27 | 6,000 | 91,620 | 59,525 | Aug 07, 2015, 04:39 PM |
JOHNSON WESLEY | Director | Aug 05, 2015 | Option Exercise | $15.81 | 5,795 | 91,619 | 31,779 | Aug 06, 2015, 02:05 PM |
JOHNSON WESLEY | Director | Aug 05, 2015 | Option Exercise | $15.27 | 6,000 | 91,620 | 37,574 | Aug 06, 2015, 02:05 PM |
GOLD JEFFREY | Director | Aug 05, 2015 | Option Exercise | $15.81 | 5,795 | 91,619 | 44,616 | Aug 06, 2015, 01:58 PM |
GOLD JEFFREY | Director | Aug 05, 2015 | Option Exercise | $15.27 | 6,000 | 91,620 | 50,411 | Aug 06, 2015, 01:58 PM |
LaPorte Steve | Director | Aug 05, 2015 | Option Exercise | $15.81 | 5,795 | 91,619 | 27,143 | Aug 06, 2015, 01:54 PM |
LaPorte Steve | Director | Aug 05, 2015 | Option Exercise | $15.27 | 6,000 | 91,620 | 32,938 | Aug 06, 2015, 01:54 PM |
Richard Stark | SVP, GM - Oncology | Aug 03, 2015 | Option Exercise | $15.54 | 1,652 | 25,672 | 31,764 | Aug 05, 2015, 09:57 PM |
DEVIVO JOSEPH | President and CEO | Aug 03, 2015 | Option Exercise | $15.54 | 2,014 | 31,298 | 202,431 | Aug 05, 2015, 09:57 PM |
Greiner Charles R | VP - Global Franchise | Aug 03, 2015 | Option Exercise | $15.54 | 1,194 | 18,555 | 24,576 | Aug 05, 2015, 09:48 PM |
Greiner Charles R | VP - Global Franchise | Aug 05, 2015 | Option Exercise | $15.81 | 13,793 | 218,067 | 24,883 | Aug 05, 2015, 09:48 PM |
Greiner Charles R | VP - Global Franchise | Aug 05, 2015 | Option Exercise | $15.27 | 14,100 | 215,307 | 38,676 | Aug 05, 2015, 09:48 PM |
Trowbridge Stephen A | SVP and General Counsel | Aug 05, 2015 | Option Exercise | $15.81 | 5,674 | 89,706 | 43,454 | Aug 05, 2015, 09:47 PM |
Trowbridge Stephen A | SVP and General Counsel | Aug 03, 2015 | Option Exercise | $15.54 | 1,312 | 20,388 | 43,735 | Aug 05, 2015, 09:47 PM |
Trowbridge Stephen A | SVP and General Counsel | Aug 05, 2015 | Option Exercise | $15.27 | 5,800 | 88,566 | 49,128 | Aug 05, 2015, 09:47 PM |
Frost Mark T | EVP and CFO | Jul 27, 2015 | Option Exercise | $15.63 | 696 | 10,878 | 39,186 | Jul 29, 2015, 08:57 PM |
DEVIVO JOSEPH | President and CEO | Jul 27, 2015 | Option Exercise | $15.63 | 2,796 | 43,701 | 204,445 | Jul 29, 2015, 08:56 PM |
SOTO JOHN | SVP and CCO | Jul 27, 2015 | Option Exercise | $15.63 | 566 | 8,847 | 23,760 | Jul 29, 2015, 08:55 PM |
Greiner Charles R | VP - Global Franchise | Jul 27, 2015 | Option Exercise | $15.63 | 411 | 6,424 | 25,770 | Jul 29, 2015, 08:54 PM |
Richard Stark | SVP, GM - Oncology | Jul 27, 2015 | Option Exercise | $15.63 | 421 | 6,580 | 32,567 | Jul 29, 2015, 08:53 PM |
Trowbridge Stephen A | SVP and General Counsel | Jul 27, 2015 | Option Exercise | $15.63 | 428 | 6,690 | 44,640 | Jul 29, 2015, 08:51 PM |
DONNELLY HOWARD W | Director | Jul 16, 2015 | Option Exercise | $15.27 | 6,000 | 91,620 | 29,659 | Jul 17, 2015, 07:02 PM |
JOHNSON WESLEY | Director | Jun 08, 2015 | Option Exercise | $16.55 | 4,649 | 76,941 | 26,308 | Jun 10, 2015, 05:47 PM |
Richard Stark | SVP, GM - Oncology | Feb 13, 2015 | Option Exercise | $15.27 | 18,100 | 276,387 | 46,801 | Feb 19, 2015, 04:20 PM |
Richard Stark | SVP, GM - Oncology | Feb 13, 2015 | Sale | $18.53 | 18,100 | 335,393 | 28,701 | Feb 19, 2015, 04:20 PM |
Richard Stark | SVP, GM - Oncology | Jan 28, 2015 | Option Exercise | $19.42 | 419 | 8,137 | 28,701 | Jan 29, 2015, 07:59 PM |
Frost Mark T | EVP and CFO | Dec 01, 2014 | Option Exercise | $17.45 | 1,856 | 32,387 | 33,913 | Dec 02, 2014, 05:01 PM |
Kapusta Matthew C | SVP, Business Development | Nov 17, 2014 | Option Exercise | $16.85 | 1,392 | 23,455 | 30,062 | Nov 19, 2014, 04:08 PM |
Greiner Charles R | VP - Global Franchise | Oct 20, 2014 | Sale | $15.63 | 3,298 | 51,548 | 22,055 | Oct 21, 2014, 06:21 PM |
SOTO JOHN | EVP and CCO | Sep 10, 2014 | Option Exercise | $13.36 | 816 | 10,902 | 18,898 | Sep 11, 2014, 07:35 PM |
DEVIVO JOSEPH | President and CEO | Sep 08, 2014 | Option Exercise | $13.55 | 2,320 | 31,436 | 179,180 | Sep 10, 2014, 05:51 PM |
GOLD JEFFREY | Director | Jul 07, 2014 | Option Exercise | $15.90 | 5,405 | 85,939 | 32,952 | Aug 14, 2014, 09:19 PM |
GOLD JEFFREY | Director | Jul 07, 2014 | Option Exercise | $13.18 | 6,000 | 79,080 | 38,357 | Aug 14, 2014, 09:19 PM |
Bourne George W. IV | CTO and COO | Aug 06, 2014 | Option Exercise | $14.75 | 574 | 8,467 | 23,613 | Aug 08, 2014, 09:45 PM |
Greiner Charles R | VP - Global Franchise | Aug 06, 2014 | Option Exercise | $14.75 | 465 | 6,859 | 25,353 | Aug 08, 2014, 09:43 PM |
Greiner Charles R | VP - Global Franchise | Aug 03, 2014 | Option Exercise | $14.69 | 1,851 | 27,191 | 27,023 | Aug 08, 2014, 09:43 PM |
Richard Stark | SVP, GM - Oncology | Aug 06, 2014 | Option Exercise | $14.75 | 477 | 7,036 | 29,120 | Aug 08, 2014, 09:38 PM |
Richard Stark | SVP, GM - Oncology | Aug 03, 2014 | Option Exercise | $14.69 | 2,009 | 29,512 | 31,249 | Aug 08, 2014, 09:38 PM |
Kapusta Matthew C | SVP, Business Development | Aug 06, 2014 | Option Exercise | $14.75 | 576 | 8,496 | 30,704 | Aug 08, 2014, 09:35 PM |
Kapusta Matthew C | SVP, Business Development | Aug 03, 2014 | Option Exercise | $14.69 | 530 | 7,786 | 31,280 | Aug 08, 2014, 09:35 PM |
DEVIVO JOSEPH | President and CEO | Aug 06, 2014 | Option Exercise | $14.75 | 1,660 | 24,485 | 181,500 | Aug 08, 2014, 09:29 PM |
DEVIVO JOSEPH | President and CEO | Aug 03, 2014 | Option Exercise | $14.69 | 2,014 | 29,586 | 183,160 | Aug 08, 2014, 09:29 PM |
Frost Mark T | EVP and CFO | Aug 06, 2014 | Option Exercise | $14.75 | 797 | 11,756 | 33,291 | Aug 08, 2014, 07:33 PM |
SOTO JOHN | SVP - Global Franchise Leader | Aug 06, 2014 | Option Exercise | $14.75 | 550 | 8,113 | 19,714 | Aug 08, 2014, 07:09 PM |
Bourne George W. IV | CTO and COO | May 21, 2014 | Option Exercise | $14.12 | 948 | 13,386 | 18,843 | May 23, 2014, 04:16 PM |
Meteny Dennis S | Director | Apr 14, 2014 | Option Exercise | $11.00 | 15,500 | 170,500 | 42,066 | May 19, 2014, 04:15 PM |
Kapusta Matthew C | SVP, Business Development | Apr 14, 2014 | Buy | $13.90 | 1,000 | 13,900 | 27,005 | Apr 16, 2014, 02:14 PM |
Richard Stark | SVP, GM - Oncology | Jan 28, 2014 | Option Exercise | $16.67 | 357 | 5,951 | 26,888 | Jan 30, 2014, 02:04 PM |
McGill Stephen | SVP, GM - International | Jan 28, 2014 | Option Exercise | $16.67 | 1,175 | 19,587 | 20,715 | Jan 30, 2014, 02:01 PM |
Bourne George W. IV | CTO and COO | Dec 17, 2013 | Option Exercise | $15.63 | 163 | 2,548 | 17,855 | Dec 18, 2013, 02:21 PM |
Kapusta Matthew C | SVP, Business Development | Nov 15, 2013 | Option Exercise | $15.62 | 1,392 | 21,743 | 23,158 | Nov 18, 2013, 05:02 PM |
Greiner Charles R | VP - Global Finance | Nov 14, 2013 | Option Exercise | $13.18 | 4,373 | 57,636 | 27,501 | Nov 15, 2013, 05:23 PM |
Greiner Charles R | VP - Global Finance | Nov 13, 2013 | Sale | $15.40 | 2,392 | 36,842 | 23,128 | Nov 15, 2013, 05:23 PM |
Greiner Charles R | VP - Global Finance | Nov 14, 2013 | Sale | $15.46 | 4,373 | 67,611 | 23,128 | Nov 15, 2013, 05:23 PM |
BUCCI VINCENT | Director | Oct 18, 2013 | Buy | $15.20 | 5,000 | 75,990 | 86,696 | Oct 21, 2013, 12:03 PM |
DONNELLY HOWARD W | Director | Oct 17, 2013 | Option Exercise | $11.00 | 20,000 | 220,000 | 35,850 | Oct 21, 2013, 12:00 PM |
DONNELLY HOWARD W | Director | Oct 17, 2013 | Sale | $15.06 | 20,000 | 301,200 | 15,850 | Oct 21, 2013, 12:00 PM |
SOTO JOHN | SVP - Global Franchise Leader | Sep 10, 2013 | Option Exercise | $11.26 | 905 | 10,190 | 14,290 | Sep 11, 2013, 04:39 PM |
DEVIVO JOSEPH | President and CEO | Sep 09, 2013 | Option Exercise | $11.10 | 2,261 | 25,097 | 74,290 | Sep 11, 2013, 04:37 PM |
Greiner Charles R | VP - Global Franchise | Sep 04, 2013 | Option Exercise | $10.96 | 795 | 8,713 | 25,520 | Sep 06, 2013, 05:06 PM |
Richard Stark | SVP, GM - Oncology | Sep 04, 2013 | Option Exercise | $10.96 | 835 | 9,152 | 27,245 | Sep 06, 2013, 05:03 PM |
Kapusta Matthew C | SVP, Business Development | Aug 03, 2013 | Option Exercise | $12.04 | 530 | 6,381 | 19,112 | Aug 06, 2013, 09:32 PM |
DEVIVO JOSEPH | President and Chief Executive | Aug 03, 2013 | Option Exercise | $12.04 | 2,358 | 28,390 | 58,213 | Aug 06, 2013, 09:31 PM |
Greiner Charles R | VP - Global Franchise | Aug 03, 2013 | Option Exercise | $12.04 | 2,045 | 24,622 | 22,564 | Aug 06, 2013, 09:29 PM |
McGill Stephen | SVP, GM - International | Aug 03, 2013 | Option Exercise | $12.04 | 2,878 | 34,651 | 17,624 | Aug 06, 2013, 09:28 PM |
Richard Stark | SVP, GM - Oncology | Aug 03, 2013 | Option Exercise | $12.04 | 2,358 | 28,390 | 24,674 | Aug 06, 2013, 09:27 PM |
Gould Kevin J | Director | Jul 22, 2013 | Buy | $12.00 | 2,700 | 32,400 | 10,950 | Jul 23, 2013, 09:36 AM |
Bourne George W. IV | CTO and COO | May 21, 2013 | Option Exercise | $10.96 | 948 | 10,390 | 11,963 | May 22, 2013, 05:45 PM |
Greiner Charles R | VP - Global Franchise | May 09, 2013 | Sale | $10.38 | 1,495 | 15,518 | 23,221 | May 16, 2013, 02:36 PM |
GOLD JEFFREY | Director | Mar 25, 2013 | Option Exercise | $6.52 | 2,508 | 16,356 | 27,741 | Mar 27, 2013, 04:02 PM |
BUCCI VINCENT | Director | Mar 12, 2013 | Buy | $10.80 | 10,000 | 108,000 | 13,000 | Mar 13, 2013, 03:33 PM |
BUCCI VINCENT | Director | Mar 12, 2013 | Buy | $10.76 | 35,000 | 376,600 | 38,000 | Mar 13, 2013, 03:33 PM |
BUCCI VINCENT | Director | Mar 12, 2013 | Buy | $10.78 | 40,000 | 431,200 | 78,696 | Mar 13, 2013, 03:33 PM |
Meteny Dennis S | Director | Mar 12, 2013 | Buy | $10.82 | 4,600 | 49,772 | 21,950 | Mar 12, 2013, 06:05 PM |
BUCCI VINCENT | Director | Feb 14, 2013 | Buy | $12.17 | 2,000 | 24,332 | 38,696 | Feb 15, 2013, 06:00 PM |
Richard Stark | SVP, GM - Oncology | Jan 28, 2013 | Option Exercise | $12.35 | 838 | 10,349 | 25,093 | Jan 30, 2013, 11:28 AM |
McGill Stephen | SVP, GM - International | Jan 28, 2013 | Option Exercise | $12.35 | 2,600 | 32,110 | 19,386 | Jan 30, 2013, 11:22 AM |
Gould Kevin J | Director | Jan 11, 2013 | Buy | $11.58 | 2,700 | 31,277 | 8,250 | Jan 14, 2013, 12:07 PM |
Kapusta Matthew C | SVP, Business Development | Nov 15, 2012 | Option Exercise | $10.12 | 1,358 | 13,743 | 19,642 | Nov 16, 2012, 09:38 AM |
GOLD JEFFREY | Director | Nov 05, 2012 | Buy | $10.56 | 1,000 | 10,560 | 25,233 | Nov 13, 2012, 10:08 AM |
Richard Stark | SVP, GM - Oncology | Nov 05, 2012 | Sale | $10.36 | 3,160 | 32,738 | 25,931 | Nov 09, 2012, 12:13 PM |
GERSUK D JOSEPH | EVP - CFO | Sep 04, 2012 | Option Exercise | $11.61 | 1,086 | 12,608 | 47,275 | Sep 11, 2012, 06:57 PM |
Richard Stark | SVP, GM - Oncology | Sep 04, 2012 | Option Exercise | $11.61 | 715 | 8,301 | 29,091 | Sep 11, 2012, 06:54 PM |
DEVIVO JOSEPH | President and CEO | Sep 07, 2012 | Option Exercise | $12.12 | 2,526 | 30,615 | 60,571 | Sep 10, 2012, 06:24 PM |
Richard Stark | SVP, GM - Oncology | Aug 03, 2012 | Option Exercise | $10.70 | 1,116 | 11,941 | 20,565 | Aug 07, 2012, 08:29 AM |
McGill Stephen | SVP, GM - International | Aug 03, 2012 | Option Exercise | $10.70 | 997 | 10,668 | 7,616 | Aug 07, 2012, 08:28 AM |
GERSUK D JOSEPH | EVP - CFO | Aug 03, 2012 | Option Exercise | $10.70 | 2,172 | 23,240 | 37,175 | Aug 07, 2012, 08:27 AM |
Etlinger Richard Scott | SVP - Global Operations | Aug 23, 2012 | Option Exercise | $10.70 | 543 | 5,810 | 5,457 | Aug 07, 2012, 08:26 AM |
DEVIVO JOSEPH | President and CEO | Jul 17, 2012 | Buy | $11.67 | 2,000 | 23,340 | 38,000 | Jul 18, 2012, 02:30 PM |
Richard Stark | SVP, GM - Oncology | May 16, 2012 | Sale | $12.42 | 2,080 | 25,827 | 20,922 | May 17, 2012, 03:12 PM |
BUCCI VINCENT | Director | Apr 12, 2012 | Buy | $11.87 | 2,000 | 23,735 | 33,846 | May 15, 2012, 06:24 PM |
ECHENBERG PAUL S | Director Emeritus | Apr 23, 2012 | Option Exercise | $6.52 | 2,091 | 13,637 | 154,412 | Apr 27, 2012, 07:15 PM |
GOLD JEFFREY | Director | Apr 25, 2012 | Option Exercise | $6.52 | 418 | 2,726 | 21,383 | Apr 27, 2012, 07:11 PM |
BUCCI VINCENT | Director | Apr 12, 2012 | Buy | $11.82 | 4,000 | 47,280 | 4,000 | Apr 13, 2012, 07:00 PM |
Gould Kevin J | Director | Apr 11, 2012 | Buy | $11.72 | 2,700 | 31,636 | 2,700 | Apr 12, 2012, 11:43 AM |
DEVIVO JOSEPH | President and CEO | Apr 09, 2012 | Buy | $11.82 | 5,000 | 59,094 | 36,000 | Apr 10, 2012, 02:27 PM |
Kapusta Matthew C | SVP, Business Development | Apr 10, 2012 | Buy | $11.40 | 1,000 | 11,397 | 16,000 | Apr 10, 2012, 02:22 PM |
BUCCI VINCENT | Director | Apr 09, 2012 | Buy | $11.80 | 2,000 | 23,596 | 31,846 | Apr 10, 2012, 02:16 PM |
BUCCI VINCENT | Director | Feb 21, 2012 | Buy | $13.44 | 2,000 | 26,878 | 29,846 | Feb 21, 2012, 05:45 PM |
BUCCI VINCENT | Director | Feb 15, 2012 | Buy | $13.25 | 2,000 | 26,494 | 27,846 | Feb 15, 2012, 02:36 PM |
BUCCI VINCENT | Director | Feb 13, 2012 | Buy | $12.93 | 1,000 | 12,927 | 25,846 | Feb 15, 2012, 02:36 PM |
DEVIVO JOSEPH | President and CEO | Feb 13, 2012 | Buy | $12.95 | 3,000 | 38,850 | 31,000 | Feb 13, 2012, 06:19 PM |
DEVIVO JOSEPH | President and CEO | Nov 16, 2011 | Buy | $14.15 | 2,500 | 35,363 | 28,000 | Nov 17, 2011, 09:04 AM |
GERSUK D JOSEPH | EVP - CFO | Sep 06, 2011 | Option Exercise | $13.49 | 1,086 | 14,650 | 38,533 | Sep 08, 2011, 05:11 PM |
GERSUK D JOSEPH | EVP - CFO | Sep 06, 2011 | Option Exercise | $13.49 | 3,000 | 40,470 | 39,619 | Sep 08, 2011, 05:11 PM |
Meteny Dennis S | Director | Aug 31, 2011 | Option Exercise | $11.00 | 5,000 | 55,000 | 14,500 | Sep 01, 2011, 03:10 PM |
BUCCI VINCENT | Director | Aug 16, 2011 | Buy | $14.11 | 3,000 | 42,330 | 3,000 | Aug 17, 2011, 05:46 PM |
BUCCI VINCENT | Director | Aug 16, 2011 | Buy | $14.01 | 3,000 | 42,025 | 3,000 | Aug 17, 2011, 05:46 PM |
McGill Stephen | SVP, GM - International | Aug 03, 2011 | Option Exercise | $13.53 | 367 | 4,966 | 7,983 | Aug 05, 2011, 08:27 PM |
GERSUK D JOSEPH | EVP - CFO | Aug 03, 2011 | Option Exercise | $13.53 | 1,358 | 18,374 | 36,619 | Aug 05, 2011, 08:24 PM |
Solano Scott J. | Interim CEO | Aug 03, 2011 | Option Exercise | $13.53 | 1,672 | 22,622 | 8,945 | Aug 05, 2011, 08:12 PM |
ECHENBERG PAUL S | Director Emeritus | Jun 01, 2011 | Option Exercise | $4.35 | 2,091 | 9,091 | 152,321 | Jun 03, 2011, 12:48 PM |
McGill Stephen | SVP, GM - International | Jan 28, 2011 | Option Exercise | $16.24 | 1,025 | 16,646 | 12,475 | Feb 02, 2011, 04:59 PM |
Keltjens Jan | President & CEO | Jan 19, 2011 | Option Exercise | $16.56 | 9,094 | 150,597 | 109,276 | Jan 21, 2011, 12:29 PM |
LaPorte Steve | Director | Oct 19, 2010 | Buy | $14.29 | 500 | 7,143 | 8,013 | Oct 20, 2010, 04:55 PM |
LaPorte Steve | Director | Oct 19, 2010 | Buy | $14.29 | 500 | 7,143 | 8,013 | Oct 20, 2010, 04:48 PM |
APPLING WILLIAM M | Vice-President - Research | Sep 07, 2010 | Option Exercise | $15.23 | 2,250 | 34,267 | 16,636 | Sep 07, 2010, 05:56 PM |
GERSUK D JOSEPH | EVP - CFO | Sep 07, 2010 | Option Exercise | $15.23 | 1,086 | 16,540 | 27,565 | Sep 07, 2010, 05:49 PM |
GERSUK D JOSEPH | EVP - CFO | Sep 07, 2010 | Option Exercise | $15.23 | 3,000 | 45,690 | 28,651 | Sep 07, 2010, 05:49 PM |
MAPES HAROLD | VP - Operations | Sep 07, 2010 | Option Exercise | $15.23 | 452 | 6,884 | 13,684 | Sep 07, 2010, 05:43 PM |
MAPES HAROLD | VP - Operations | Sep 07, 2010 | Option Exercise | $15.23 | 1,250 | 19,037 | 14,934 | Sep 07, 2010, 05:43 PM |
McCarthy Shawn P | SVP - General Manager | Aug 17, 2010 | Option Exercise | $16.04 | 1,358 | 21,782 | 10,392 | Aug 30, 2010, 05:27 PM |
McCarthy Shawn P | SVP - General Manager | Aug 17, 2010 | Option Exercise | $16.04 | 1,590 | 25,504 | 6,410 | Aug 17, 2010, 05:27 PM |
Keltjens Jan | President & CEO | Jan 19, 2010 | Option Exercise | $17.22 | 8,149 | 140,326 | 96,851 | Aug 05, 2010, 03:06 PM |
Owner | Relationship | Date | Value($) |
Trowbridge Stephen A | EVP and CFO | 02/29/2024 | 8,999 |
Trowbridge Stephen A | EVP and CFO | 07/19/2023 | 62,217 |
Helsel Dave | SVP Global Operations and R&D | 07/19/2023 | 31,015 |
Centea Scott | SVP/GM, VIT | 07/19/2023 | 24,227 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/19/2023 | 27,679 |
Clemmer James C | President and CEO | 07/19/2023 | 305,920 |
Clemmer James C | President and CEO | 07/19/2023 | 101,501 |
Helsel Dave | SVP Global Operations and R&D | 07/19/2023 | 14,049 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/19/2023 | 12,524 |
Centea Scott | SVP/GM, VIT | 07/19/2023 | 10,972 |
Trowbridge Stephen A | EVP and CFO | 07/19/2023 | 28,178 |
Trowbridge Stephen A | EVP and CFO | 07/21/2023 | 5,770 |
Trowbridge Stephen A | EVP and CFO | 07/20/2023 | 6,267 |
Clemmer James C | President and CEO | 07/21/2023 | 29,168 |
Clemmer James C | President and CEO | 07/20/2023 | 26,063 |
Helsel Dave | SVP Global Operations and R&D | 07/20/2023 | 2,902 |
Helsel Dave | SVP Global Operations and R&D | 07/21/2023 | 3,157 |
Centea Scott | SVP/GM, VIT | 07/21/2023 | 2,206 |
Centea Scott | SVP/GM, VIT | 07/20/2023 | 2,910 |
Piccinini Laura | SVP International | 07/21/2023 | 3,572 |
Piccinini Laura | SVP International | 07/20/2023 | 5,384 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/21/2023 | 3,417 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/20/2023 | 3,138 |
Trowbridge Stephen A | EVP and CFO | 07/14/2023 | 13,116 |
Trowbridge Stephen A | EVP and CFO | 07/17/2023 | 3,595 |
Clemmer James C | President and CEO | 07/17/2023 | 21,625 |
Clemmer James C | President and CEO | 07/14/2023 | 47,245 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/17/2023 | 2,667 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/14/2023 | 5,739 |
Centea Scott | SVP/GM, VIT | 07/14/2023 | 4,979 |
Centea Scott | SVP/GM, VIT | 07/17/2023 | 3,356 |
Helsel Dave | SVP Global Operations and R&D | 07/17/2023 | 2,992 |
Helsel Dave | SVP Global Operations and R&D | 07/14/2023 | 6,539 |
Piccinini Laura | SVP International | 06/01/2023 | 13,496 |
Trowbridge Stephen A | EVP and CFO | 02/03/2023 | 7,454 |
ROSENZWEIG RICHARD C | SVP and General Counsel | 02/01/2023 | 15,190 |
Helsel Dave | SVP Global Operations and R&D | 01/31/2023 | 59,997 |
Trowbridge Stephen A | EVP and CFO | 10/12/2022 | 14,967 |
Clemmer James C | President and CEO | 10/10/2022 | 150,000 |
Helsel Dave | SVP Global Operations and R&D | 07/29/2022 | 112,200 |
JOHNSON WESLEY | Director | 07/15/2022 | 96,047 |
JOHNSON WESLEY | Director | 07/15/2022 | 96,051 |
Trowbridge Stephen A | EVP and CFO | 07/15/2022 | 264,325 |
Trowbridge Stephen A | EVP and CFO | 07/15/2022 | 235,390 |
Meteny Dennis S | Director | 07/12/2022 | 96,056 |
Meteny Dennis S | Director | 07/12/2022 | 96,051 |
Helsel Dave | SVP Global Operations and R&D | 07/07/2022 | 25,120 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/07/2022 | 22,142 |
Nighan Warren JR | SVP Quality and Regulatory | 07/07/2022 | 18,876 |
Trowbridge Stephen A | EVP and CFO | 07/07/2022 | 30,995 |
Clemmer James C | President and CEO | 07/07/2022 | 176,110 |
Helsel Dave | SVP Global Operations and R&D | 04/28/2022 | 78,832 |
DONNELLY HOWARD W | Director | 04/20/2022 | 96,051 |
JOHNSON WESLEY | Director | 04/12/2022 | 30,215 |
JOHNSON WESLEY | Director | 04/11/2022 | 142,623 |
Trowbridge Stephen A | EVP and CFO | 02/03/2022 | 11,940 |
ROSENZWEIG RICHARD C | SVP and General Counsel | 02/01/2022 | 25,444 |
Trowbridge Stephen A | EVP and CFO | 01/12/2022 | 22,640 |
Clemmer James C | President and CEO | 01/11/2022 | 228,400 |
Centea Scott | Sr. VP/GM, Global VIT | 10/31/2021 | 27,990 |
Helsel Dave | SVP Global Operations and R&D | 10/20/2021 | 97,727 |
Centea Scott | Sr. VP/GM, Global VIT | 10/15/2021 | 201,240 |
Centea Scott | Sr. VP/GM, Global VIT | 10/15/2021 | 335,040 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 10/05/2021 | 178,309 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 10/05/2021 | 291,808 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 08/12/2021 | 85,418 |
Clemmer James C | President and CEO | 08/12/2021 | 587,608 |
Trowbridge Stephen A | EVP and CFO | 08/12/2021 | 113,881 |
Helsel Dave | SVP Global Operations and R&D | 08/12/2021 | 91,340 |
Helsel Dave | SVP Global Operations and R&D | 08/12/2021 | 21,505 |
Clemmer James C | President and CEO | 08/12/2021 | 246,183 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 08/12/2021 | 19,158 |
Trowbridge Stephen A | EVP and CFO | 08/12/2021 | 33,594 |
Meteny Dennis S | Director | 07/28/2021 | 83,810 |
Meteny Dennis S | Director | 07/28/2021 | 83,829 |
JOHNSON WESLEY | Director | 07/28/2021 | 83,810 |
JOHNSON WESLEY | Director | 07/28/2021 | 83,829 |
Centea Scott | Sr. VP/GM, Global VIT | 07/26/2021 | 10,936 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/26/2021 | 8,300 |
Trowbridge Stephen A | EVP and CFO | 07/26/2021 | 9,213 |
Clemmer James C | President and CEO | 07/26/2021 | 54,941 |
Trowbridge Stephen A | EVP and CFO | 07/17/2021 | 8,765 |
Trowbridge Stephen A | EVP and CFO | 07/14/2021 | 33,936 |
Trowbridge Stephen A | EVP and CFO | 07/18/2021 | 9,904 |
Helsel Dave | SVP Global Operations and R&D | 07/18/2021 | 10,325 |
Helsel Dave | SVP Global Operations and R&D | 07/17/2021 | 7,279 |
Helsel Dave | SVP Global Operations and R&D | 07/14/2021 | 16,915 |
Centea Scott | SVP/GM, VIT | 07/14/2021 | 13,215 |
Centea Scott | SVP/GM, VIT | 07/18/2021 | 8,517 |
Centea Scott | SVP/GM, VIT | 07/17/2021 | 8,394 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/18/2021 | 7,428 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/17/2021 | 6,487 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/14/2021 | 15,092 |
Clemmer James C | President and CEO | 07/14/2021 | 122,159 |
Clemmer James C | President and CEO | 07/18/2021 | 36,719 |
Clemmer James C | President and CEO | 07/17/2021 | 52,764 |
Helsel Dave | SVP Global Operations and R&D | 04/14/2021 | 83,755 |
DONNELLY HOWARD W | Director | 04/01/2021 | 83,826 |
DONNELLY HOWARD W | Director | 04/01/2021 | 83,829 |
Trowbridge Stephen A | EVP and CFO | 02/03/2021 | 10,139 |
JOHNSON WESLEY | Director | 01/20/2021 | 120,445 |
Helsel Dave | SVP Global Operations and R&D | 12/18/2020 | 10,475 |
Centea Scott | SVP/GM, VIT | 10/31/2020 | 9,016 |
Trowbridge Stephen A | EVP and CFO | 08/11/2020 | 9,502 |
Clemmer James C | President and CEO | 07/31/2020 | 330,400 |
Trowbridge Stephen A | EVP and CFO | 07/27/2020 | 2,570 |
Trowbridge Stephen A | EVP and CFO | 07/26/2020 | 2,763 |
Clemmer James C | President and CEO | 07/26/2020 | 16,509 |
Clemmer James C | President and CEO | 07/27/2020 | 15,831 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/27/2020 | 2,279 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/26/2020 | 2,490 |
Trowbridge Stephen A | EVP and CFO | 07/18/2020 | 3,684 |
Trowbridge Stephen A | EVP and CFO | 07/17/2020 | 3,349 |
Helsel Dave | SVP Global Operations and R&D | 07/17/2020 | 2,403 |
Helsel Dave | SVP Global Operations and R&D | 07/18/2020 | 3,334 |
Clemmer James C | President and CEO | 07/18/2020 | 13,658 |
Clemmer James C | President and CEO | 07/17/2020 | 20,159 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/18/2020 | 2,763 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/17/2020 | 2,479 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 05/23/2020 | 9,259 |
Clemmer James C | President and CEO | 04/04/2020 | 43,426 |
Boucher Brent J. | SVP and GM of Oncology | 02/12/2020 | 6,365 |
Boucher Brent J. | SVP and GM of Oncology | 01/17/2020 | 7,585 |
Helsel Dave | SVP Global Operations and R&D | 12/18/2019 | 11,460 |
Clemmer James C | President and CEO | 10/25/2019 | 212,850 |
Greiner Michael | EVP and CFO | 08/18/2019 | 15,777 |
Trowbridge Stephen A | SVP and General Counsel | 07/12/2019 | 25,691 |
Greiner Michael | EVP and CFO | 07/12/2019 | 74,579 |
Simpson Robert Arthur | SVP/GM, Global Vascular | 07/12/2019 | 111,825 |
Clemmer James C | President and CEO | 07/12/2019 | 2,084,315 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/12/2019 | 22,764 |
JOHNSON WESLEY | Director | 08/06/2019 | 71,011 |
JOHNSON WESLEY | Director | 08/06/2019 | 71,022 |
Clemmer James C | President and CEO | 07/26/2019 | 38,145 |
Clemmer James C | President and CEO | 07/27/2019 | 36,634 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/27/2019 | 5,269 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/26/2019 | 5,766 |
Simpson Robert Arthur | SVP/GM, Global Vascular | 07/26/2019 | 6,455 |
Trowbridge Stephen A | SVP and General Counsel | 07/27/2019 | 5,959 |
Trowbridge Stephen A | SVP and General Counsel | 07/26/2019 | 6,392 |
Trowbridge Stephen A | SVP and General Counsel | 07/22/2019 | 7,590 |
Greiner Michael | EVP and CFO | 07/26/2019 | 10,675 |
Greiner Michael | EVP and CFO | 07/18/2019 | 12,401 |
Clemmer James C | President and CEO | 07/18/2019 | 31,089 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/18/2019 | 6,287 |
Trowbridge Stephen A | SVP and General Counsel | 07/22/2019 | 7,590 |
Trowbridge Stephen A | SVP and General Counsel | 07/18/2019 | 8,375 |
Boucher Brent J. | SVP and GM of Oncology | 07/18/2019 | 8,031 |
Helsel Dave | SVP Global Operations and R&D | 07/18/2019 | 8,720 |
Simpson Robert Arthur | SVP/GM, Global Vascular | 07/18/2019 | 8,440 |
GOLD JEFFREY | Director | 07/12/2019 | 71,024 |
GOLD JEFFREY | Director | 07/12/2019 | 71,022 |
Gould Kevin J | Director | 07/16/2019 | 154,462 |
Gould Kevin J | Director | 07/16/2019 | 292,793 |
Meteny Dennis S | Director | 06/28/2019 | 71,022 |
Meteny Dennis S | Director | 06/28/2019 | 71,022 |
Meteny Dennis S | Director | 05/31/2019 | 71,026 |
Meteny Dennis S | Director | 05/31/2019 | 71,022 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 05/23/2019 | 16,431 |
Trowbridge Stephen A | SVP and General Counsel | 04/24/2019 | 27,224 |
Clemmer James C | President and CEO | 04/04/2019 | 97,124 |
Boucher Brent J. | SVP and GM of Oncology | 02/12/2019 | 11,221 |
Simpson Robert Arthur | SVP/GM, Global Vascular | 01/31/2019 | 20,699 |
Greiner Michael | EVP and CFO | 11/07/2018 | 41,747 |
Trowbridge Stephen A | SVP and General Counsel | 07/12/2018 | 24,088 |
Trowbridge Stephen A | SVP and General Counsel | 07/27/2018 | 6,105 |
Clemmer James C | President and CEO | 07/27/2018 | 37,528 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/27/2018 | 5,398 |
Trowbridge Stephen A | SVP and General Counsel | 07/26/2018 | 6,695 |
Trowbridge Stephen A | SVP and General Counsel | 07/25/2018 | 8,407 |
Trowbridge Stephen A | SVP and General Counsel | 07/22/2018 | 7,693 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/26/2018 | 6,039 |
Greiner Michael | EVP and CFO | 07/26/2018 | 11,181 |
Clemmer James C | President and CEO | 07/26/2018 | 39,953 |
Simpson Robert Arthur | SVP/GM, Global Vascular | 07/26/2018 | 6,739 |
GOLD JEFFREY | Director | 07/06/2018 | 94,695 |
GOLD JEFFREY | Director | 07/06/2018 | 94,710 |
Meteny Dennis S | Director | 06/21/2018 | 189,414 |
Meteny Dennis S | Director | 06/21/2018 | 189,420 |
DONNELLY HOWARD W | Director | 06/21/2018 | 71,030 |
DONNELLY HOWARD W | Director | 06/21/2018 | 71,022 |
GOLD JEFFREY | Director | 06/21/2018 | 94,707 |
GOLD JEFFREY | Director | 06/21/2018 | 94,710 |
JOHNSON WESLEY | Director | 06/22/2018 | 189,424 |
JOHNSON WESLEY | Director | 06/22/2018 | 189,420 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 05/23/2018 | 16,846 |
Trowbridge Stephen A | SVP and General Counsel | 04/24/2018 | 25,293 |
Simpson Robert Arthur | SVP/GM, Global Vascular | 01/31/2018 | 18,385 |
DONNELLY HOWARD W | Director | 11/21/2017 | 189,408 |
DONNELLY HOWARD W | Director | 11/21/2017 | 189,420 |
Richard Stark | SVP, GM - Oncology | 11/15/2017 | 313,815 |
Richard Stark | SVP, GM - Oncology | 11/15/2017 | 446,493 |
Gould Kevin J | Director | 09/12/2017 | 547,168 |
Gould Kevin J | Director | 09/12/2017 | 547,170 |
Trowbridge Stephen A | SVP and General Counsel | 08/06/2017 | 8,197 |
JOHNSON WESLEY | Director | 07/25/2017 | 220,488 |
JOHNSON WESLEY | Director | 07/25/2017 | 220,500 |
Richard Stark | SVP, GM - Oncology | 08/06/2017 | 8,313 |
Meteny Dennis S | Director | 07/25/2017 | 220,488 |
Meteny Dennis S | Director | 07/25/2017 | 220,500 |
Clemmer James C | President and CEO | 07/27/2017 | 32,033 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 07/27/2017 | 4,614 |
GOLD JEFFREY | Director | 07/25/2017 | 220,488 |
GOLD JEFFREY | Director | 07/25/2017 | 220,500 |
Richard Stark | SVP, GM - Oncology | 07/25/2017 | 7,396 |
Richard Stark | SVP, GM - Oncology | 07/22/2017 | 6,602 |
Trowbridge Stephen A | SVP and General Counsel | 07/25/2017 | 7,481 |
Trowbridge Stephen A | SVP and General Counsel | 07/22/2017 | 6,670 |
REED JAN STERN | Director | 07/24/2017 | 5,056 |
DONNELLY HOWARD W | Director | 07/21/2017 | 78,600 |
Clemmer James C | President and CEO | 07/21/2017 | 78,950 |
Clemmer James C | President and CEO | 07/20/2017 | 312,800 |
DONNELLY HOWARD W | Director | 06/19/2017 | 220,496 |
DONNELLY HOWARD W | Director | 06/19/2017 | 220,500 |
Campbell Chad Thomas | SVP/GM, Vascular Access | 05/23/2017 | 12,466 |
Trowbridge Stephen A | SVP and General Counsel | 04/24/2017 | 25,011 |
Burgstahler David F | Director | 04/12/2017 | 37,600,000 |
Avista Capital Partners GP, LLC | 10% Owner | 04/12/2017 | 37,600,000 |
Clemmer James C | President and CEO | 04/04/2017 | 76,906 |
LaPorte Steve | Director | 01/13/2017 | 250,880 |
LaPorte Steve | Director | 01/13/2017 | 220,500 |
Burgstahler David F | Director | 11/18/2016 | 6,408,510 |
Burgstahler David F | Director | 11/18/2016 | 32,791,491 |
Avista Capital Partners GP, LLC | 10% Owner | 11/18/2016 | 6,408,510 |
Avista Capital Partners GP, LLC | 10% Owner | 11/18/2016 | 32,791,491 |
Meteny Dennis S | Director | 08/31/2016 | 159,479 |
Meteny Dennis S | Director | 08/31/2016 | 159,480 |
GOLD JEFFREY | Director | 08/31/2016 | 159,479 |
GOLD JEFFREY | Director | 08/31/2016 | 159,480 |
Trowbridge Stephen A | SVP and General Counsel | 07/11/2016 | 24,587 |
Trowbridge Stephen A | SVP and General Counsel | 08/08/2016 | 7,699 |
Burgstahler David F | Director | 08/05/2016 | 32,895,000 |
Avista Capital Partners GP, LLC | 10% Owner | 08/05/2016 | 32,763,420 |
Trowbridge Stephen A | SVP and General Counsel | 07/25/2016 | 7,239 |
Trowbridge Stephen A | SVP and General Counsel | 07/22/2016 | 6,591 |
DONNELLY HOWARD W | Director | 07/15/2016 | 159,473 |
DONNELLY HOWARD W | Director | 07/15/2016 | 159,480 |
JOHNSON WESLEY | Director | 07/15/2016 | 159,473 |
JOHNSON WESLEY | Director | 07/15/2016 | 159,480 |
LaPorte Steve | Director | 07/13/2016 | 159,480 |
LaPorte Steve | Director | 07/13/2016 | 159,480 |
Greiner Charles R | VP - Global Franchise | 05/06/2016 | 43,183 |
Trowbridge Stephen A | SVP and General Counsel | 04/25/2016 | 16,608 |
Trowbridge Stephen A | SVP and General Counsel | 04/21/2016 | 129,465 |
Trowbridge Stephen A | SVP and General Counsel | 04/25/2016 | 29,719 |
SOTO JOHN | SVP and CCO | 09/10/2015 | 11,840 |
DEVIVO JOSEPH | President and CEO | 09/08/2015 | 33,686 |
SOTO JOHN | SVP and CCO | 08/06/2015 | 7,828 |
Trowbridge Stephen A | SVP and General Counsel | 08/06/2015 | 7,716 |
Greiner Charles R | VP - Global Franchise | 08/06/2015 | 7,398 |
Richard Stark | SVP, GM - Oncology | 08/06/2015 | 7,589 |
Frost Mark T | EVP and CFO | 08/06/2015 | 12,680 |
DEVIVO JOSEPH | President and CEO | 08/06/2015 | 26,411 |
Meteny Dennis S | Director | 08/05/2015 | 91,619 |
Meteny Dennis S | Director | 08/05/2015 | 91,620 |
JOHNSON WESLEY | Director | 08/05/2015 | 91,619 |
JOHNSON WESLEY | Director | 08/05/2015 | 91,620 |
GOLD JEFFREY | Director | 08/05/2015 | 91,619 |
GOLD JEFFREY | Director | 08/05/2015 | 91,620 |
LaPorte Steve | Director | 08/05/2015 | 91,619 |
LaPorte Steve | Director | 08/05/2015 | 91,620 |
Richard Stark | SVP, GM - Oncology | 08/03/2015 | 25,672 |
DEVIVO JOSEPH | President and CEO | 08/03/2015 | 31,298 |
Greiner Charles R | VP - Global Franchise | 08/03/2015 | 18,555 |
Greiner Charles R | VP - Global Franchise | 08/05/2015 | 218,067 |
Greiner Charles R | VP - Global Franchise | 08/05/2015 | 215,307 |
Trowbridge Stephen A | SVP and General Counsel | 08/05/2015 | 89,706 |
Trowbridge Stephen A | SVP and General Counsel | 08/03/2015 | 20,388 |
Trowbridge Stephen A | SVP and General Counsel | 08/05/2015 | 88,566 |
Frost Mark T | EVP and CFO | 07/27/2015 | 10,878 |
DEVIVO JOSEPH | President and CEO | 07/27/2015 | 43,701 |
SOTO JOHN | SVP and CCO | 07/27/2015 | 8,847 |
Greiner Charles R | VP - Global Franchise | 07/27/2015 | 6,424 |
Richard Stark | SVP, GM - Oncology | 07/27/2015 | 6,580 |
Trowbridge Stephen A | SVP and General Counsel | 07/27/2015 | 6,690 |
DONNELLY HOWARD W | Director | 07/16/2015 | 91,620 |
JOHNSON WESLEY | Director | 06/08/2015 | 76,941 |
Richard Stark | SVP, GM - Oncology | 02/13/2015 | 276,387 |
Richard Stark | SVP, GM - Oncology | 02/13/2015 | 335,393 |
Richard Stark | SVP, GM - Oncology | 01/28/2015 | 8,137 |
Frost Mark T | EVP and CFO | 12/01/2014 | 32,387 |
Kapusta Matthew C | SVP, Business Development | 11/17/2014 | 23,455 |
Greiner Charles R | VP - Global Franchise | 10/20/2014 | 51,548 |
SOTO JOHN | EVP and CCO | 09/10/2014 | 10,902 |
DEVIVO JOSEPH | President and CEO | 09/08/2014 | 31,436 |
GOLD JEFFREY | Director | 07/07/2014 | 85,939 |
GOLD JEFFREY | Director | 07/07/2014 | 79,080 |
Bourne George W. IV | CTO and COO | 08/06/2014 | 8,467 |
Greiner Charles R | VP - Global Franchise | 08/06/2014 | 6,859 |
Greiner Charles R | VP - Global Franchise | 08/03/2014 | 27,191 |
Richard Stark | SVP, GM - Oncology | 08/06/2014 | 7,036 |
Richard Stark | SVP, GM - Oncology | 08/03/2014 | 29,512 |
Kapusta Matthew C | SVP, Business Development | 08/06/2014 | 8,496 |
Kapusta Matthew C | SVP, Business Development | 08/03/2014 | 7,786 |
DEVIVO JOSEPH | President and CEO | 08/06/2014 | 24,485 |
DEVIVO JOSEPH | President and CEO | 08/03/2014 | 29,586 |
Frost Mark T | EVP and CFO | 08/06/2014 | 11,756 |
SOTO JOHN | SVP - Global Franchise Leader | 08/06/2014 | 8,113 |
Bourne George W. IV | CTO and COO | 05/21/2014 | 13,386 |
Meteny Dennis S | Director | 04/14/2014 | 170,500 |
Kapusta Matthew C | SVP, Business Development | 04/14/2014 | 13,900 |
Richard Stark | SVP, GM - Oncology | 01/28/2014 | 5,951 |
McGill Stephen | SVP, GM - International | 01/28/2014 | 19,587 |
Bourne George W. IV | CTO and COO | 12/17/2013 | 2,548 |
Kapusta Matthew C | SVP, Business Development | 11/15/2013 | 21,743 |
Greiner Charles R | VP - Global Finance | 11/14/2013 | 57,636 |
Greiner Charles R | VP - Global Finance | 11/13/2013 | 36,842 |
Greiner Charles R | VP - Global Finance | 11/14/2013 | 67,611 |
BUCCI VINCENT | Director | 10/18/2013 | 75,990 |
DONNELLY HOWARD W | Director | 10/17/2013 | 220,000 |
DONNELLY HOWARD W | Director | 10/17/2013 | 301,200 |
SOTO JOHN | SVP - Global Franchise Leader | 09/10/2013 | 10,190 |
DEVIVO JOSEPH | President and CEO | 09/09/2013 | 25,097 |
Greiner Charles R | VP - Global Franchise | 09/04/2013 | 8,713 |
Richard Stark | SVP, GM - Oncology | 09/04/2013 | 9,152 |
Kapusta Matthew C | SVP, Business Development | 08/03/2013 | 6,381 |
DEVIVO JOSEPH | President and Chief Executive | 08/03/2013 | 28,390 |
Greiner Charles R | VP - Global Franchise | 08/03/2013 | 24,622 |
McGill Stephen | SVP, GM - International | 08/03/2013 | 34,651 |
Richard Stark | SVP, GM - Oncology | 08/03/2013 | 28,390 |
Gould Kevin J | Director | 07/22/2013 | 32,400 |
Bourne George W. IV | CTO and COO | 05/21/2013 | 10,390 |
Greiner Charles R | VP - Global Franchise | 05/09/2013 | 15,518 |
GOLD JEFFREY | Director | 03/25/2013 | 16,356 |
BUCCI VINCENT | Director | 03/12/2013 | 108,000 |
BUCCI VINCENT | Director | 03/12/2013 | 376,600 |
BUCCI VINCENT | Director | 03/12/2013 | 431,200 |
Meteny Dennis S | Director | 03/12/2013 | 49,772 |
BUCCI VINCENT | Director | 02/14/2013 | 24,332 |
Richard Stark | SVP, GM - Oncology | 01/28/2013 | 10,349 |
McGill Stephen | SVP, GM - International | 01/28/2013 | 32,110 |
Gould Kevin J | Director | 01/11/2013 | 31,277 |
Kapusta Matthew C | SVP, Business Development | 11/15/2012 | 13,743 |
GOLD JEFFREY | Director | 11/05/2012 | 10,560 |
Richard Stark | SVP, GM - Oncology | 11/05/2012 | 32,738 |
GERSUK D JOSEPH | EVP - CFO | 09/04/2012 | 12,608 |
Richard Stark | SVP, GM - Oncology | 09/04/2012 | 8,301 |
DEVIVO JOSEPH | President and CEO | 09/07/2012 | 30,615 |
Richard Stark | SVP, GM - Oncology | 08/03/2012 | 11,941 |
McGill Stephen | SVP, GM - International | 08/03/2012 | 10,668 |
GERSUK D JOSEPH | EVP - CFO | 08/03/2012 | 23,240 |
Etlinger Richard Scott | SVP - Global Operations | 08/23/2012 | 5,810 |
DEVIVO JOSEPH | President and CEO | 07/17/2012 | 23,340 |
Richard Stark | SVP, GM - Oncology | 05/16/2012 | 25,827 |
BUCCI VINCENT | Director | 04/12/2012 | 23,735 |
ECHENBERG PAUL S | Director Emeritus | 04/23/2012 | 13,637 |
GOLD JEFFREY | Director | 04/25/2012 | 2,726 |
BUCCI VINCENT | Director | 04/12/2012 | 47,280 |
Gould Kevin J | Director | 04/11/2012 | 31,636 |
DEVIVO JOSEPH | President and CEO | 04/09/2012 | 59,094 |
Kapusta Matthew C | SVP, Business Development | 04/10/2012 | 11,397 |
BUCCI VINCENT | Director | 04/09/2012 | 23,596 |
BUCCI VINCENT | Director | 02/21/2012 | 26,878 |
BUCCI VINCENT | Director | 02/15/2012 | 26,494 |
BUCCI VINCENT | Director | 02/13/2012 | 12,927 |
DEVIVO JOSEPH | President and CEO | 02/13/2012 | 38,850 |
DEVIVO JOSEPH | President and CEO | 11/16/2011 | 35,363 |
GERSUK D JOSEPH | EVP - CFO | 09/06/2011 | 14,650 |
GERSUK D JOSEPH | EVP - CFO | 09/06/2011 | 40,470 |
Meteny Dennis S | Director | 08/31/2011 | 55,000 |
BUCCI VINCENT | Director | 08/16/2011 | 42,330 |
BUCCI VINCENT | Director | 08/16/2011 | 42,025 |
McGill Stephen | SVP, GM - International | 08/03/2011 | 4,966 |
GERSUK D JOSEPH | EVP - CFO | 08/03/2011 | 18,374 |
Solano Scott J. | Interim CEO | 08/03/2011 | 22,622 |
ECHENBERG PAUL S | Director Emeritus | 06/01/2011 | 9,091 |
McGill Stephen | SVP, GM - International | 01/28/2011 | 16,646 |
Keltjens Jan | President & CEO | 01/19/2011 | 150,597 |
LaPorte Steve | Director | 10/19/2010 | 7,143 |
LaPorte Steve | Director | 10/19/2010 | 7,143 |
APPLING WILLIAM M | Vice-President - Research | 09/07/2010 | 34,267 |
GERSUK D JOSEPH | EVP - CFO | 09/07/2010 | 16,540 |
GERSUK D JOSEPH | EVP - CFO | 09/07/2010 | 45,690 |
MAPES HAROLD | VP - Operations | 09/07/2010 | 6,884 |
MAPES HAROLD | VP - Operations | 09/07/2010 | 19,037 |
McCarthy Shawn P | SVP - General Manager | 08/17/2010 | 21,782 |
McCarthy Shawn P | SVP - General Manager | 08/17/2010 | 25,504 |
Keltjens Jan | President & CEO | 01/19/2010 | 140,326 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 5,044,098 | 0.00101% | 21.2% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 896,808 | 0.00074% | 5.84% | Other |
RENAISSANCE TECHNOLOGIES LLC | 864,083 | 0.01% | 31.26% | Other |
AQR CAPITAL MANAGEMENT LLC | 694,226 | 0.01% | 211.09% | Other |
D. E. SHAW & CO., INC. | 604,451 | 0.00414% | -11.89% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 116,596 | 0.00174% | Exited | Event Driven |
TUDOR INVESTMENT CORP ET AL | 99,380 | 0.00627% | 0.35% | Event Driven, Other |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 15,352 | 0.00222% | New | Other |
Period of Report: 11/30/2023
10-K/10-Q Filings: View